Science is moving forward in understanding the key inflammatory pathways involved in psoriasis and psoriatic arthritis, which has led to the development of targeted, effective therapies for patients with these diseases. But with these advances, it’s becoming more and more important for clinicians to understand how to choose treatment options appropriately and how to discuss them with patients.

To explore the use of available treatments for psoriatic arthritis, Dr. Matt Birnholz sits down with Dr. Philip Mease and Dr. Allan Gibofsky.

Overproduction of the cytokine interleukin 6 (IL-6) has been implicated in the pathogenesis of rheumatoid arthritis and is a critical driver of the inflammatory and destructive aspects of the disease.

Dr. Alan Epstein, Clinical Professor of Medicine at the University of Pennsylvania School of Medicine, talks about IL-6’s pivotal role in the development of RA.

Rheumatoid Arthritis: Addressing Unmet Needs is sponsored by Lilly. Content for this non-certified educational series is produced and controlled by ReachMD. This series is intended for healthcare professionals only.

Dr. Jeffrey Curtis, William J. Koopman Endowed Professor in the Division of Clinical Immunology and Rheumatology at the University of Alabama at Birmingham, explores how precision medicine could revolutionize patient care for rheumatoid arthritis.

Rheumatoid Arthritis: Addressing Unmet Needs is sponsored by Lilly. Content for this a non-certified educational series is produced and controlled by ReachMD. This series is intended for healthcare professionals only.

What's in store for the treatment of RA days, months, and years from now? Hear from top rheumatologists about what the future holds for patients with rheumatoid arthritis and the health care professionals striving to improve their quality of life.

You’ll hear from:

• Dr. Jeffrey Curtis, William J. Koopman Endowed Professor in the Division of Clinical Immunology and Rheumatology at the University of Alabama at Birmingham
• Dr. Alan Epstein, Clinical Professor of Medicine at the University of Pennsylvania School of Medicine
• Dr. Michele Meltzer, Associate Professor at Jefferson University Hospitals
• Dr. Farhan Tahir, staff rheumatologist at Cancer Treatment Centers of America

Rheumatoid Arthritis: Addressing Unmet Needs is sponsored by Lilly. Content for this a non-certified educational series is produced and controlled by ReachMD. This series is intended for healthcare professionals only.

Dr. Jeffrey Curtis, William J. Koopman Endowed Professor in the Division of Clinical Immunology and Rheumatology at the University of Alabama at Birmingham, talks about the problem of settling for insufficient therapeutic responses in RA treatments, how to recognize when it's happening, and what health professionals can do to curb the trend.

Rheumatoid Arthritis: Addressing Unmet Needs is sponsored by Lilly. Content for this a non-certified educational series is produced and controlled by ReachMD. This series is intended for healthcare professionals only.

Dr. Farhan Tahir, staff rheumatologist at Cancer Treatment Centers of America in Philadelphia, PA talks about ways in which management approaches for RA patients have evolved over time, such as the drive toward earlier diagnosis and treatment.

Rheumatoid Arthritis: Addressing Unmet Needs is sponsored by Lilly. Content for this a non-certified educational series is produced and controlled by ReachMD. This series is intended for healthcare professionals only.

Dr. Robin Dore, Clinical Professor of Medicine at UCLA's David Geffen School of Medicine in Los Angeles, CA diagrams the JAK-STAT pathway as it relates to inflammatoty change and RA disease progression.

Rheumatoid Arthritis: Addressing Unmet Needs is sponsored by Lilly. Content for this a non-certified educational series is produced and controlled by ReachMD. This series is intended for healthcare professionals only.

Dr. Michele Meltzer, Associate Professor at Jefferson University Hospitals in Philadelphia, examines the reasons why many patients have advanced rheumatoid arthritis by the time they see a rheumatologist to treat the disease.

Rheumatoid Arthritis: Addressing Unmet Needs is sponsored by Lilly. Content for this a non-certified educational series is produced and controlled by ReachMD. This series is intended for healthcare professionals only.

Dr. Alan Epstein, Clinical Professor of Medicine at the University of Pennsylvania School of Medicine, shares insights on the molecular mechanisms of inflammatory change in RA, and the effects of inhibiting the JAK-STAT pathway responsible for disease progression.

Rheumatoid Arthritis: Addressing Unmet Needs is sponsored by Lilly. Content for this a non-certified educational series is produced and controlled by ReachMD. This series is intended for healthcare professionals only.

Dr. Jeffrey Curtis, William J. Koopman Endowed Professor in the Division of Clinical Immunology and Rheumatology at the University of Alabama at Birmingham, talks about what every new rheumatologist should know when starting out.

Rheumatoid Arthritis: Addressing Unmet Needs is sponsored by Lilly. Content for this a non-certified educational series is produced and controlled by ReachMD. This series is intended for healthcare professionals only.